NEW YORK — Vitrectomy using balanced saline solution without tissue plasminogen activator is effective for displacement of thick submacular hemorrhage, according to a speaker here. “As you all know, ...

In 2001, the US Food and Drug Administration approved recombinant tissue plasminogen activator (alteplase, Cathflo Activase) to reestablish patency of central catheters occluded, presumably, by a ...

The usual cause of stroke is an acute interruption of cerebral blood flow that compromises tissue energy stores. The major consequence of this metabolic deprivation is dysfunction of excitatory ...

A new analysis supports the use of intravenous (IV) tenecteplase over IV alteplase (tissue plasminogen activator) for treatment of acute ischemic stroke. The analysis found that patients with ischemic ...

A new study published online in the Journal of Trauma and Acute Care Surgery in March 2020 reports that the anticoagulation drug tPA could be a potential aid in managing respiratory failure in ...

August 19, 2009 (UPDATED August 24, 2009) — In May, the American Heart Association (AHA)/American Stroke Association (ASA) gave the green light to the use of tissue plasminogen activator (tPA) to ...

Clinical Relevance of Invasion Factors Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 for Individualized Therapy Decisions in Primary Breast Cancer Is Greatest When ...

Measurements of Proteases or Protease System Components in Blood to Enhance Prediction of Disease Risk or Outcome in Possible Cancer To assess whether preoperative plasma levels of urokinase-type ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global tissue plasminogen activator market is estimated to be valued at US$ 2,455.4 million in 2020 and is expected to exhibit a ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 72, No. 3 (Mar., 1975), pp. 1132-1136 (5 pages) The fibrinolytic activity of proteases secreted by chick embryo ...